{"id":"https://openalex.org/W2120953264","doi":"https://doi.org/10.1093/brain/awh127","title":"Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies","display_name":"Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies","publication_year":2004,"publication_date":"2004-02-26","ids":{"openalex":"https://openalex.org/W2120953264","doi":"https://doi.org/10.1093/brain/awh127","mag":"2120953264","pmid":"https://pubmed.ncbi.nlm.nih.gov/14985267"},"language":"en","primary_location":{"id":"doi:10.1093/brain/awh127","doi":"https://doi.org/10.1093/brain/awh127","is_oa":false,"landing_page_url":"https://doi.org/10.1093/brain/awh127","pdf_url":null,"source":{"id":"https://openalex.org/S118357697","display_name":"Brain","issn_l":"0006-8950","issn":["0006-8950","1460-2156"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Brain","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047528718","display_name":"G. Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111381250","display_name":"Hebei Medical University","ror":"https://ror.org/04eymdx19","country_code":"CN","type":"education","lineage":["https://openalex.org/I111381250"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["CN","US"],"is_corresponding":true,"raw_author_name":"G. Zhang","raw_affiliation_strings":["Department of Neurology, Johns Hopkins University, Baltimore, MD, USA","Hebei Medical University","Johns Hopkins University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Johns Hopkins University, Baltimore, MD, USA","institution_ids":["https://openalex.org/I145311948"]},{"raw_affiliation_string":"Hebei Medical University","institution_ids":["https://openalex.org/I111381250"]},{"raw_affiliation_string":"Johns Hopkins University","institution_ids":["https://openalex.org/I145311948"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5047528718"],"corresponding_institution_ids":["https://openalex.org/I111381250","https://openalex.org/I145311948"],"apc_list":{"value":4224,"currency":"GBP","value_usd":5570},"apc_paid":null,"fwci":3.6014,"has_fulltext":true,"cited_by_count":83,"citation_normalized_percentile":{"value":0.92375766,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"127","issue":"5","first_page":"1085","last_page":"1100"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11735","display_name":"Peripheral Neuropathies and Disorders","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11735","display_name":"Peripheral Neuropathies and Disorders","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11627","display_name":"Autoimmune Neurological Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-ganglioside-antibodies","display_name":"anti-ganglioside antibodies","score":0.9929999709129333},{"id":"https://openalex.org/keywords/gd1a","display_name":"GD1a","score":0.6869999766349792},{"id":"https://openalex.org/keywords/gm1-ganglioside","display_name":"GM1 ganglioside","score":0.8529999852180481},{"id":"https://openalex.org/keywords/neuronal-cytotoxicity","display_name":"neuronal cytotoxicity","score":0.8360000252723694},{"id":"https://openalex.org/keywords/complement-activation","display_name":"complement activation","score":0.7570000290870667},{"id":"https://openalex.org/keywords/intravenous-immunoglobulin","display_name":"intravenous immunoglobulin","score":0.9850000143051147},{"id":"https://openalex.org/keywords/anti-idiotypic-antibodies","display_name":"anti-idiotypic antibodies","score":0.9679999947547913}],"concepts":[{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.7709932327270508},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.7109576463699341},{"id":"https://openalex.org/C2777331542","wikidata":"https://www.wikidata.org/wiki/Q419287","display_name":"Ganglioside","level":2,"score":0.6643670201301575},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6128168702125549},{"id":"https://openalex.org/C2780898057","wikidata":"https://www.wikidata.org/wiki/Q79448","display_name":"Immunoglobulin G","level":3,"score":0.5347138047218323},{"id":"https://openalex.org/C2909763950","wikidata":"https://www.wikidata.org/wiki/Q338912","display_name":"Intravenous Immunoglobulins","level":3,"score":0.5210872888565063},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5172905921936035},{"id":"https://openalex.org/C2780052305","wikidata":"https://www.wikidata.org/wiki/Q6934690","display_name":"Multifocal motor neuropathy","level":4,"score":0.47292664647102356},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4077815115451813},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.28182756900787354},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2783041000366211},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.24334624409675598},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09636971354484558},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.07820549607276917},{"id":"https://openalex.org/C21715850","wikidata":"https://www.wikidata.org/wiki/Q2720968","display_name":"Mismatch negativity","level":3,"score":0.0},{"id":"https://openalex.org/C522805319","wikidata":"https://www.wikidata.org/wiki/Q179965","display_name":"Electroencephalography","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001323","descriptor_name":"Autoantibodies","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D003165","descriptor_name":"Complement System Proteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D003601","descriptor_name":"Cytotoxicity Tests, Immunologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005732","descriptor_name":"Gangliosides","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D006168","descriptor_name":"Guinea Pigs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007770","descriptor_name":"L-Lactate Dehydrogenase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016756","descriptor_name":"Immunoglobulins, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D020275","descriptor_name":"Guillain-Barre Syndrome","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D020275","descriptor_name":"Guillain-Barre Syndrome","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1093/brain/awh127","doi":"https://doi.org/10.1093/brain/awh127","is_oa":false,"landing_page_url":"https://doi.org/10.1093/brain/awh127","pdf_url":null,"source":{"id":"https://openalex.org/S118357697","display_name":"Brain","issn_l":"0006-8950","issn":["0006-8950","1460-2156"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Brain","raw_type":"journal-article"},{"id":"pmid:14985267","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14985267","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Brain : a journal of neurology","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.563.3731","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.563.3731","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://brain.oxfordjournals.org/content/127/5/1085.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6807518394","display_name":"Pathogenesis of Anti-ganglioside Antibody-Mediated Neuropathies","funder_award_id":"R01NS042888","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"}],"funders":[{"id":"https://openalex.org/F4320310145","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337359","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":79,"referenced_works":["https://openalex.org/W55350511","https://openalex.org/W959574011","https://openalex.org/W1505326537","https://openalex.org/W1514594273","https://openalex.org/W1557092891","https://openalex.org/W1905643418","https://openalex.org/W1918730945","https://openalex.org/W1963517178","https://openalex.org/W1968278997","https://openalex.org/W1971868683","https://openalex.org/W1975236167","https://openalex.org/W1980891120","https://openalex.org/W1981601027","https://openalex.org/W1984098270","https://openalex.org/W1986286135","https://openalex.org/W1988667788","https://openalex.org/W1994325619","https://openalex.org/W1995085418","https://openalex.org/W1997156404","https://openalex.org/W1999463245","https://openalex.org/W2002031062","https://openalex.org/W2002434755","https://openalex.org/W2004183671","https://openalex.org/W2007020463","https://openalex.org/W2008093279","https://openalex.org/W2010209497","https://openalex.org/W2013362643","https://openalex.org/W2014292324","https://openalex.org/W2015728729","https://openalex.org/W2021949020","https://openalex.org/W2025568648","https://openalex.org/W2027139906","https://openalex.org/W2027276520","https://openalex.org/W2027502308","https://openalex.org/W2034926063","https://openalex.org/W2039788052","https://openalex.org/W2041588298","https://openalex.org/W2047175827","https://openalex.org/W2048172256","https://openalex.org/W2049293049","https://openalex.org/W2050307985","https://openalex.org/W2051952845","https://openalex.org/W2060838010","https://openalex.org/W2061064015","https://openalex.org/W2064640622","https://openalex.org/W2066968930","https://openalex.org/W2068681394","https://openalex.org/W2071302728","https://openalex.org/W2072765129","https://openalex.org/W2073714591","https://openalex.org/W2082190687","https://openalex.org/W2084414198","https://openalex.org/W2085479239","https://openalex.org/W2085970433","https://openalex.org/W2096146439","https://openalex.org/W2097548528","https://openalex.org/W2110719788","https://openalex.org/W2116748512","https://openalex.org/W2119301121","https://openalex.org/W2121636757","https://openalex.org/W2122912629","https://openalex.org/W2125618200","https://openalex.org/W2126962846","https://openalex.org/W2127923368","https://openalex.org/W2129614621","https://openalex.org/W2146789864","https://openalex.org/W2147467901","https://openalex.org/W2150632109","https://openalex.org/W2155337151","https://openalex.org/W2157199750","https://openalex.org/W2162896225","https://openalex.org/W2163788135","https://openalex.org/W2170968580","https://openalex.org/W2187061108","https://openalex.org/W2215442559","https://openalex.org/W2385839235","https://openalex.org/W3021831804","https://openalex.org/W4230919551","https://openalex.org/W4250686131"],"related_works":["https://openalex.org/W7099137967","https://openalex.org/W2168569726","https://openalex.org/W2136955615","https://openalex.org/W2041585253","https://openalex.org/W6921433358","https://openalex.org/W1979773004","https://openalex.org/W1982913734","https://openalex.org/W2082931808","https://openalex.org/W6996275467","https://openalex.org/W2014708282"],"abstract_inverted_index":{"Antibodies":[0],"against":[1],"GD1a,":[2],"GM1":[3,157],"and":[4,20,55,69,96,115,129,191,216],"related":[5,37],"gangliosides":[6],"are":[7,43],"frequently":[8],"present":[9],"in":[10,24,79,173,185,211],"patients":[11,212],"with":[12,53,213],"the":[13,57,84,141,156,180],"motor":[14],"variant":[15,26],"of":[16,27,59,86,182,193,206],"Guillain-Barr\u00e9":[17],"syndrome":[18],"(GBS),":[19],"their":[21],"pathological":[22,72],"role":[23,85],"this":[25,132,139,174,186],"GBS":[28,110],"is":[29,65,135],"now":[30,164],"widely":[31],"accepted.":[32],"However,":[33],"two":[34],"basic":[35],"issues":[36],"to":[38,147,151,220],"anti-ganglioside":[39,49,100,113,117,152,209,222],"antibody-mediated":[40,101,153,223],"neural":[41,224],"injury":[42,154],"not":[44,66],"completely":[45],"resolved:":[46],"(i)":[47,207],"some":[48],"antibodies":[50,64,114,118,190,210],"can":[51,200],"cross-react":[52],"glycoproteins":[54],"therefore":[56],"nature":[58],"antigens":[60],"targeted":[61],"by":[62,123],"these":[63,92],"well":[67],"established;":[68],"(ii)":[70,217],"although":[71],"studies":[73],"suggest":[74],"that":[75,108,131,179],"complement":[76,87,136,194],"activation":[77],"occurs":[78],"GBS,":[80,169],"experimental":[81],"data":[82,177],"for":[83,168,204],"remain":[88],"inconclusive.":[89],"To":[90],"address":[91],"issues,":[93],"we":[94],"developed":[95],"characterized":[97],"a":[98,165],"simple":[99,197],"cytotoxicity":[102,172,198],"assay.":[103,175],"Our":[104,176],"results":[105],"demonstrate":[106],"first,":[107],"both":[109],"sera":[111],"containing":[112],"monoclonal":[116],"cause":[119],"neuronal":[120],"cell":[121,126,133,143],"lysis":[122,134],"targeting":[124],"specific":[125],"surface":[127],"gangliosides,":[128],"secondly,":[130],"dependent.":[137],"In":[138],"assay,":[140],"GD1a":[142],"membrane":[144],"pool":[145],"appears":[146],"be":[148,202],"more":[149],"susceptible":[150],"than":[155],"pool.":[158],"Further,":[159],"human":[160],"intravenous":[161],"immunoglobulin":[162],"(i.v.Ig),":[163],"standard":[166],"treatment":[167],"significantly":[170],"decreased":[171],"indicate":[178],"mechanisms":[181],"i.v.Ig-mediated":[183],"protection":[184],"assay":[187,199],"include":[188],"anti-idiotypic":[189],"downregulation":[192],"activation.":[195],"This":[196],"potentially":[201],"used":[203],"screening":[205],"pathogenic":[208],"immune-mediated":[214],"neuropathies;":[215],"new/experimental":[218],"therapies":[219],"prevent":[221],"injury.":[225]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}